The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet Aggregation
Jia Ke,1,* Meng-Ting Li,1,* Ya-Jing Huo,1 Yan-Qiong Cheng,2 Shu-Fen Guo,1 Yang Wu,1 Lei Zhang,3 Jianpeng Ma,4 Ai-Jun Liu,2 Yan Han1 1Department of Neurology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine,...
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-08-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/the-synergistic-effect-of-ginkgo-biloba-extract-50-and-aspirin-against-peer-reviewed-fulltext-article-DDDT |
id |
doaj-eba222dd5b424283872f1bd53992341e |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ke J Li MT Huo YJ Cheng YQ Guo SF Wu Y Zhang L Ma J Liu AJ Han Y |
spellingShingle |
Ke J Li MT Huo YJ Cheng YQ Guo SF Wu Y Zhang L Ma J Liu AJ Han Y The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet Aggregation Drug Design, Development and Therapy ginkgo biloba aspirin antiplatelet synergistic effect chinese herb arachidonic acid |
author_facet |
Ke J Li MT Huo YJ Cheng YQ Guo SF Wu Y Zhang L Ma J Liu AJ Han Y |
author_sort |
Ke J |
title |
The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet Aggregation |
title_short |
The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet Aggregation |
title_full |
The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet Aggregation |
title_fullStr |
The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet Aggregation |
title_full_unstemmed |
The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet Aggregation |
title_sort |
synergistic effect of ginkgo biloba extract 50 and aspirin against platelet aggregation |
publisher |
Dove Medical Press |
series |
Drug Design, Development and Therapy |
issn |
1177-8881 |
publishDate |
2021-08-01 |
description |
Jia Ke,1,* Meng-Ting Li,1,* Ya-Jing Huo,1 Yan-Qiong Cheng,2 Shu-Fen Guo,1 Yang Wu,1 Lei Zhang,3 Jianpeng Ma,4 Ai-Jun Liu,2 Yan Han1 1Department of Neurology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China; 2Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai, People’s Republic of China; 3Department of Vascular Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China; 4Multiscale Research Institute of Complex Systems, Fudan University, Shanghai, People’s Republic of China*These authors contributed equally to this workCorrespondence: Ai-Jun LiuDepartment of Pharmacology, School of Pharmacy, Second Military Medical University, 800 Xiangyin Road, Yangpu, Shanghai, 200433, People’s Republic of ChinaEmail mrliuaijun@163.comYan HanDepartment of Neurology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, 110 Ganhe Road, Hongkou, Shanghai, 200437, People’s Republic of ChinaTel +86 21 51322043Email hanyan.2006@aliyun.comPurpose: We aimed to investigate potential synergistic antiplatelet effects of Ginkgo biloba extract (GBE50) in combination with aspirin using in vitro models.Methods: Arachidonic acid (AA), platelet activating factor (PAF), adenosine 5ʹ-diphosphate (ADP) and collagen were used as inducers. The antiplatelet effects of GBE50, aspirin and 1:1 combination of GBE50 and aspirin were detected by microplate method using rabbit platelets. Synergy finder 2.0 was used to analyze the synergistic antiplatelet effect. The compounds in GBE50 were identified by UPLC-Q/TOF-MS analysis and the candidate compounds were screened by TCMSP database. The targets of candidate compounds and aspirin were obtained in TCMSP, CCGs, Swiss target prediction database and drugbank. Targets involving platelet aggregation were obtained from GenCLiP database. Compound-target network was constructed and GO and KEGG enrichment analyses were performed to identify the critical biological processes and signaling pathways. The levels of thromboxane B2 (TXB2), cyclic adenosine monophosphate (cAMP) and PAF receptor (PAFR) were detected by ELISA to determine the effects of GBE50, aspirin and their combination on these pathways.Results: GBE50 combined with aspirin inhibited platelet aggregation more effectively. The combination displayed synergistic antiplatelet effects in AA-induced platelet aggregation, and additive antiplatelet effects occurred in PAF, ADP and collagen induced platelet aggregation. Seven compounds were identified as candidate compounds in GBE50. Enrichment analyses revealed that GBE50 could interfere with platelet aggregation via cAMP pathway, AA metabolism and calcium signaling pathway, and aspirin could regulate platelet aggregation through AA metabolism and platelet activation. ELISA experiments showed that GBE50 combined with aspirin could increase cAMP levels in resting platelets, and decreased the levels of TXB2 and PAFR.Conclusion: Our study indicated that GBE50 combined with aspirin could enhance the antiplatelet effects. They exerted both synergistic and additive effects in restraining platelet aggregation. The study highlighted the potential application of GBE50 as a supplementary therapy to treat thrombosis-related diseases.Keywords: Ginkgo biloba, aspirin, antiplatelet, synergistic effect, Chinese herb, arachidonic acid |
topic |
ginkgo biloba aspirin antiplatelet synergistic effect chinese herb arachidonic acid |
url |
https://www.dovepress.com/the-synergistic-effect-of-ginkgo-biloba-extract-50-and-aspirin-against-peer-reviewed-fulltext-article-DDDT |
work_keys_str_mv |
AT kej thesynergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation AT limt thesynergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation AT huoyj thesynergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation AT chengyq thesynergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation AT guosf thesynergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation AT wuy thesynergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation AT zhangl thesynergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation AT maj thesynergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation AT liuaj thesynergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation AT hany thesynergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation AT kej synergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation AT limt synergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation AT huoyj synergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation AT chengyq synergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation AT guosf synergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation AT wuy synergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation AT zhangl synergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation AT maj synergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation AT liuaj synergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation AT hany synergisticeffectofginkgobilobaextract50andaspirinagainstplateletaggregation |
_version_ |
1721206360577671168 |
spelling |
doaj-eba222dd5b424283872f1bd53992341e2021-08-15T20:13:46ZengDove Medical PressDrug Design, Development and Therapy1177-88812021-08-01Volume 153543356067902The Synergistic Effect of Ginkgo biloba Extract 50 and Aspirin Against Platelet AggregationKe JLi MTHuo YJCheng YQGuo SFWu YZhang LMa JLiu AJHan YJia Ke,1,* Meng-Ting Li,1,* Ya-Jing Huo,1 Yan-Qiong Cheng,2 Shu-Fen Guo,1 Yang Wu,1 Lei Zhang,3 Jianpeng Ma,4 Ai-Jun Liu,2 Yan Han1 1Department of Neurology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China; 2Department of Pharmacology, School of Pharmacy, Second Military Medical University, Shanghai, People’s Republic of China; 3Department of Vascular Surgery, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People’s Republic of China; 4Multiscale Research Institute of Complex Systems, Fudan University, Shanghai, People’s Republic of China*These authors contributed equally to this workCorrespondence: Ai-Jun LiuDepartment of Pharmacology, School of Pharmacy, Second Military Medical University, 800 Xiangyin Road, Yangpu, Shanghai, 200433, People’s Republic of ChinaEmail mrliuaijun@163.comYan HanDepartment of Neurology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, 110 Ganhe Road, Hongkou, Shanghai, 200437, People’s Republic of ChinaTel +86 21 51322043Email hanyan.2006@aliyun.comPurpose: We aimed to investigate potential synergistic antiplatelet effects of Ginkgo biloba extract (GBE50) in combination with aspirin using in vitro models.Methods: Arachidonic acid (AA), platelet activating factor (PAF), adenosine 5ʹ-diphosphate (ADP) and collagen were used as inducers. The antiplatelet effects of GBE50, aspirin and 1:1 combination of GBE50 and aspirin were detected by microplate method using rabbit platelets. Synergy finder 2.0 was used to analyze the synergistic antiplatelet effect. The compounds in GBE50 were identified by UPLC-Q/TOF-MS analysis and the candidate compounds were screened by TCMSP database. The targets of candidate compounds and aspirin were obtained in TCMSP, CCGs, Swiss target prediction database and drugbank. Targets involving platelet aggregation were obtained from GenCLiP database. Compound-target network was constructed and GO and KEGG enrichment analyses were performed to identify the critical biological processes and signaling pathways. The levels of thromboxane B2 (TXB2), cyclic adenosine monophosphate (cAMP) and PAF receptor (PAFR) were detected by ELISA to determine the effects of GBE50, aspirin and their combination on these pathways.Results: GBE50 combined with aspirin inhibited platelet aggregation more effectively. The combination displayed synergistic antiplatelet effects in AA-induced platelet aggregation, and additive antiplatelet effects occurred in PAF, ADP and collagen induced platelet aggregation. Seven compounds were identified as candidate compounds in GBE50. Enrichment analyses revealed that GBE50 could interfere with platelet aggregation via cAMP pathway, AA metabolism and calcium signaling pathway, and aspirin could regulate platelet aggregation through AA metabolism and platelet activation. ELISA experiments showed that GBE50 combined with aspirin could increase cAMP levels in resting platelets, and decreased the levels of TXB2 and PAFR.Conclusion: Our study indicated that GBE50 combined with aspirin could enhance the antiplatelet effects. They exerted both synergistic and additive effects in restraining platelet aggregation. The study highlighted the potential application of GBE50 as a supplementary therapy to treat thrombosis-related diseases.Keywords: Ginkgo biloba, aspirin, antiplatelet, synergistic effect, Chinese herb, arachidonic acidhttps://www.dovepress.com/the-synergistic-effect-of-ginkgo-biloba-extract-50-and-aspirin-against-peer-reviewed-fulltext-article-DDDTginkgo bilobaaspirinantiplateletsynergistic effectchinese herbarachidonic acid |